Findings suggest tetracyclines pose risks in pediatric patients, indicating the need to limit their prescriptions.
There are few if any reasons for using tetracycline drugs in children less than 8 years old. This class of antibiotics is capable of producing many adverse effects, two of which are specific for younger children and one of which is irreversible. Accordingly, it is difficult to justify the continued availability of drop or syrup formulations of tetracyclines. As long as they continue to be marketed, physicians who care for children should make every effort to discourage their use and curtail prescribing tetracycline for pediatric patients.
No takes yet. Share an insight, caveat, or question.
Yaffe et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: